Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment. - Wikidata - awgldk - TriplyDB

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.

http://www.wikidata.org/entity/Q36929734

about

C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma Heterogeneity of epidermal growth factor receptor mutations in lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements: A case report.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors "One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer.Current status of research and treatment for non-small cell lung cancer in never-smoking females.The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor.

P2860

Q34031219-071BDDCA-6C21-4103-ADC0-DD99776C58C3 Q34293223-EF225A80-D005-4B79-8500-F1E1CFE1A14D Q34404209-84BB4545-0E28-4D3E-ABD9-3E3C5C0F4C09 Q34564071-7F232E9F-C318-4688-8283-AD9B082EF823 Q35055942-CC5EA41F-0223-436D-8C99-E86F3AF2FA63 Q37376360-977540C0-A3EB-4FBF-AC34-0897846BB480 Q37698439-8D2776BD-9F85-43BF-B92F-65B09341D7BB Q39298725-F838FAC0-3228-46AE-BF9F-CCE4AC756AC5 Q47115593-C94B1207-F1CF-40B2-AA6F-0E2559DA2191

P2860

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.

http://www.wikidata.org/entity/Q36929734

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.

@en

type

label

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.

@en

prefLabel

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.

@en

P1433

Q36929734-B823C8C4-0746-40BC-BE0C-4576EEDA879D

P1476

Q36929734-BE5F997C-05B2-433A-BFCA-4E373987C0B8

P2093

Q36929734-CF20FF7C-B5CD-4ABA-BB1F-BCF8831A9C46

Q36929734-DA8592F7-28EE-4F76-9493-74F1B41430AB

Q36929734-E3A2A743-437B-4B78-9802-E06A96792535

P2860

Q36929734-08AA6FA0-96D2-4FAB-A399-677CE783D6C4

Q36929734-0D5B50E4-7985-427C-9E13-6056AEE9305D

Q36929734-0DEE0946-1B4C-46BA-81AA-2A0311902315

Q36929734-2BF0AB43-97CC-408E-9E67-0C3C7DAA243B

Q36929734-2D64FE0F-EC66-4CBA-B8BB-488887D02F45

Q36929734-2E78716F-EC1E-4F95-A445-2C0BDB41DCFD

Q36929734-2EC6EA3D-5371-41DF-BC3F-44B138529AC3

Q36929734-32EAB729-8B70-450F-AAD8-E6D946225339

Q36929734-354FDDF8-4924-4F84-947F-B748DAC4CD04

Q36929734-362DA39D-87C6-4701-A831-0165052B9B92

P304

Q36929734-BBF27BA4-2091-495D-B9B6-FF75907FB663

P31

Q36929734-B0183D06-E703-45CE-812B-266ABB3BF93C

P356

Q36929734-415A045F-2AEC-4DA8-A116-C6BA0C0CF663

P407

Q36929734-9E29DB11-2991-444E-9EA7-BE38077E5B92

P478

Q36929734-09D9786A-DD5D-4043-9A8C-D4AF195544B1

P577

Q36929734-B3CE2AC9-0169-40B2-A543-72493932305C

P5875

Q36929734-1AF3619C-8248-43B3-ADBA-E01EDC3B2F5A

P698

Q36929734-4FEA877F-2639-4153-90AC-2F0CB9CD2F5D

P932

Q36929734-0058413B-326D-4A45-AA89-216EEF79CB67

P356

P1433

Cancer Management and Research

P1476

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.

@en

P2093

Hiroyasu Kaneda

http://www.w3.org/2001/XMLSchema#string

Isamu Okamoto

http://www.w3.org/2001/XMLSchema#string

Takeshi Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

Anaplastic lymphoma kinase: signalling in development and disease

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

P304

91-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S32973

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240306865

http://www.w3.org/2001/XMLSchema#string

P698

23785245

http://www.w3.org/2001/XMLSchema#string

P932

3682814

http://www.w3.org/2001/XMLSchema#string